0001657045 false 0001657045 2023-08-24 2023-08-24 iso4217:USD xbrli:shares iso4217:USD xbrli:shares

 

 

 

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

 

FORM 8-K

CURRENT REPORT

 

Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934

 

Date of Report (Date of earliest event reported): August 24, 2023

 

 

NEXT-ChemX Corporation
(Exact name of registrant as specified in its charter)

 

Nevada   000-56379   32-0446353
(State or other jurisdiction
of incorporation)
  (Commission
File Number)
  (IRS Employer
Identification No.)

 

1980 Festival Plaza Drive, Summerlin South, 300,

Las Vegas, NV

 

 

89135

(Address of Principal Executive Offices)   (Zip Code)

 

(725) 867-0789

Registrant’s telephone number, including area code

 

Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:

 

Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)
   
Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)
   
Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))
   
Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))

 

Title of each class   Trading Symbol(s)   Name of each exchange on which registered
N/A   N/A   N/A

 

 

 

 

 

 

Item 8.01 Other Events

 

NEXT-ChemX Corporation (the “Company”) has appointed Empire Stock Transfer Inc., Inc. a Nevada corporation having its principal offices at 1859 Witney Mesa Drive, Henderson, NV 89014 (“Empire”) as its transfer agent and shareholder support provider, effective August 24, 2023. All of the Company’s directly held shares of common stock were transferred from Equity Stock Transfer, Inc. to Empire’s platform. A copy of the Company’s letter to its shareholders is attached hereto as Exhibit 99.1 and incorporated herein by reference.

 

Item 9.01 Financial Statement and Exhibits.

 

(d) Exhibits.

 

The following documents are filed herewith:

 

Exhibit No.   Description
     
Exhibit 99.1   Shareholder Letter, concerning: Transfer Agent Change
     
104   Cover Page Interactive Data File (embedded within the Inline XBRL document)

 

 

 

 

Signatures

 

Pursuant to the requirements of the Securities Exchange Act of 1934, the Registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

 

Date: August 29, 2023 By: /s/ J. Michael Johnson
    Name: J. Michael Johnson
    Title: President